# Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function

> **NCT05105009** · PHASE1 · COMPLETED · sponsor: **Instituto Nacional de Cardiologia Ignacio Chavez** · enrollment: 50 (actual)

## Conditions studied

- Chronic Kidney Failure

## Interventions

- **DRUG:** Furosemide Injection
- **DRUG:** Creatinine Powder
- **DRUG:** Iohexol

## Key facts

- **NCT ID:** NCT05105009
- **Lead sponsor:** Instituto Nacional de Cardiologia Ignacio Chavez
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-03
- **Primary completion:** 2023-10-21
- **Final completion:** 2024-08-27
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105009, "Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05105009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*